Strategic Acquisitions Knipper Health has recently expanded its platform through the acquisition of eBlu Solutions to streamline patient onboarding, benefit verification, and prior authorization. This creates cross-sell opportunities to offer integrated onboarding and enrollment capabilities to current clients seeking faster therapy initiation.

Leadership Change Recent appointment of Willis Chandler as CEO signals potential strategic pivots and growth initiatives. Engage to align with new leadership on expansion plans, partnerships, and potential renewals or upsell of technology-enabled services such as MSM, 3PL, and CPS.

Integrated Platform Samplicity and Knipper 3PL with secure logistics and serialization capabilities position Knipper as a one-stop solution for life sciences brands. Target pharmaceutical and biotech clients needing end-to-end sample management, warehousing, and compliant distribution.

Regulatory Footprint Comprehensive compliance stack including DSCSA serialization, FDA/GMP controls, AICPS SOC accreditations, and cold-chain capabilities indicates suitability for high-regulation products. Upsell secure storage, tracking, and audit-ready packaging to manufacturers with sensitive or temperature-controlled therapies.

Geographic & Facility Growth Expansion of facilities and ongoing operations in North America, with a Charlestown midwest distribution facility, suggests capacity for regional scale and faster distribution. Approach regional manufacturers and distributors seeking reliable, scalable 3PL and distribution services.